Endodontic bioceramics: current and futurity aspects
Open Access
- 12 January 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oral Health
- Vol. 6, 1699547
Abstract
Excellent bioactivity and biocompatibility make bioceramics a popular choice in dentistry, especially in endodontics. The most commonly utilised bioceramic in endodontics is mineral trioxide aggregate (MTA). Several emerging bioceramics showed promise for endodontic treatment. This study discusses bioceramics and their use in endodontic treatments like as root-end filling, root canal therapy, vital pulp therapy, apexification/regenerative endodontic treatment, perforation repair, and root defect repair. The applicable research from 1990 to 2023 was screened using keywords in PubMed and Web of Science. According to current research, MTA in the management of endodontic disease is well supported. New bioceramics including Biodentine, EndoSequence, and calcium-enriched mixes have demonstrated encouraging clinical results, but additional controlled trials must be conducted to establish their use in endodontics. To address endodontic problems, bioceramics must be improved for their biologic activity, including antibacterial activity, mechanical qualities, and reduced setting time and solubility. The purpose of this review is to provide an overview of the state of bioceramic technology and to investigate potential avenues for further investigation to improve its regenerative and therapeutic potential in endodontics. Research Question: What developments and potential uses can enhance the endodontic bioceramic-based therapies' regeneration results?Keywords
This publication has 130 references indexed in Scilit:
- Elective full pulpotomy in mature permanent teeth diagnosed with symptomatic irreversible pulpitis: a two years retrospective studyClinical Oral Investigations, 2024
- Effect of revascularisation and apexification procedures on biomechanical behaviour of immature maxillary central incisor teeth: a three-dimensional finite element analysis studyClinical Oral Investigations, 2021
- Premixed bioceramics versus mineral trioxide aggregate in furcal perforation repair of primary molars: in vitro and in vivo studyClinical Oral Investigations, 2021
- Mineral trioxide aggregate (MTA) inhibits osteoclastogenesis and osteoclast activation through calcium and aluminum activitiesClinical Oral Investigations, 2020
- Effects of fast- and slow-setting calcium silicate–based root-end filling materials on the outcome of endodontic microsurgery: a retrospective study up to 6 yearsClinical Oral Investigations, 2019
- Periradicular inflammatory response, bone resorption, and cementum repair after sealing of furcation perforation with mineral trioxide aggregate (MTA Angelus™) or Biodentine™Clinical Oral Investigations, 2019
- Biodentine™ material characteristics and clinical applications: a 3 year literature review and updateEuropean Archives of Paediatric Dentistry, 2018
- In vitro evaluation of different dental materials used for the treatment of extensive cervical root defects using human periodontal cellsClinical Oral Investigations, 2016
- Prognostic factors in direct pulp capping with mineral trioxide aggregate or calcium hydroxide: 2- to 6-year follow-upClinical Oral Investigations, 2016
- MTA versus Ca(OH)2 in apexification of non-vital immature permanent teeth: a randomized clinical trial comparisonClinical Oral Investigations, 2014